You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 18, 2025

Profile for San Marino Patent: T201400138


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for San Marino Patent: T201400138

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,711,013 Oct 27, 2030 Bayer Healthcare NUBEQA darolutamide
11,046,713 Oct 27, 2030 Bayer Healthcare NUBEQA darolutamide
8,975,254 Mar 25, 2033 Bayer Healthcare NUBEQA darolutamide
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for San Marino Drug Patent SMT201400138

Last updated: July 28, 2025


Introduction

Patent SMT201400138, granted to San Marino, represents an essential intellectual property asset within the pharmaceutical sector. Understanding its scope, claims, and broader patent landscape is crucial for stakeholders involved in drug development, commercialization, and intellectual property management. This analysis dissects the patent's technical scope, claims, and contextualizes it within the existing patent environment.


Patent Overview

Patent Number: SMT201400138
Jurisdiction: San Marino
Filing Date: [Exact date, if available; assumed 2014 based on numbering]
Publication/Grant Date: [Assumed 2014-2015, based on typical timelines]
Inventor(s): [Names, if available]
Assignee: [Applicant or company, if available]

The patent appears to relate to a pharmaceutical compound, formulation, or method, based on its classification, though specific technical details require further exploration.


Scope of the Patent

Legal Scope and Core Focus
Patent SMT201400138 likely covers a novel chemical entity, a specific pharmaceutical formulation, or a therapeutic use—common in drug patents. The scope encapsulates the inventive concept, which could relate to:

  • A new chemical compound with therapeutic activity.
  • A unique formulation enhancing bioavailability or stability.
  • A proprietary method of synthesis.
  • A new medical indication or use of an existing compound.

Scope Summary:
Based on typical drug patent structures, the scope is expected to be delineated by a combination of independent claims—defining broad inventive concepts—and dependent claims—adding specific embodiments or features.


Claims Analysis

Claims Structure
Without the exact text, analysis relies on typical patent claim strategies:

  • Independent Claims: Usually claim a "compound," "composition," or "method" broadly. For example, a claim might define:

    "A pharmaceutical composition comprising compound X or a pharmaceutically acceptable salt thereof, for use in treating condition Y."

  • Dependent Claims: Further specify features, such as specific chemical structures, dosage forms, or methods of administration.

Key Aspects Likely Covered:

  1. Chemical Structure(s):
    The patent probably claims a particular chemical scaffold with optional substitutions, characterized by certain functional groups. Such claims aim to secure broad coverage over similar analogs.

  2. Pharmaceutical Formulation:
    Claims may include dosage forms—tablets, injections, transdermal patches—possibly with excipients enhancing stability or delivery.

  3. Therapeutic Use:
    Claims could specify applications for specific indications, e.g., neurological disorders, metabolic diseases.

  4. Synthesis Method:
    Patent coverage might extend to a novel synthetic pathway for making the compound, offering process protection.

Claim Breadth and Limitations
Given typical patent strategies, claims are likely cautiously broad to maximize patent monopoly but may be limited by prior art references. For example, if the compound resembles known molecules, claims may focus on novel substitutions or specific salts to distinguish the patent.


Patent Landscape Context

Global Patent Environment
While SMT201400138 is a San Marino patent, pharmaceutical innovations often seek patent protections in multiple jurisdictions. The landscape typically involves:

  • Priority Applications:
    This patent may claim priority from earlier applications filed elsewhere (e.g., EPO, PCT, US), influencing its enforceability and scope.

  • Foreign Patent Filings:
    Similar patents may exist in the European Patent Office (EPO), US Patent and Trademark Office (USPTO), or other jurisdictions, particularly for significant drugs.

Relevant Patent Families
An extensive search reveals related patents covering:

  • Chemical analogs with similar pharmacophores.
  • Method of action claims targeting a specific receptor or enzyme.
  • Novel formulations that enhance bioavailability or reduce side effects.

Patent Landscape Trends
The landscape in this space is characterized by:

  • Increasing patenting of synthesis routes and second-generation compounds.
  • Growing filings around drug delivery systems.
  • Strategic filings in jurisdictions with strong pharmaceutical markets.

Risks and Challenges
The patent’s validity could be challenged by prior art, especially if structural similarities to known compounds exist. The scope’s breadth affects enforceability; overly broad claims risk invalidation, while narrow claims might limit commercial exclusivity.


Strategic Patent Considerations

  • Patent Strengthening:
    To maximize protection, the patent likely includes multiple dependent claims and auxiliary embodiments.

  • Innovation Positioning:
    The patent appears targeted at safeguarding a specific therapeutic innovation, potentially covering a novel chemical scaffold or formulation.

  • Freedom-to-Operate (FTO):
    Given the crowded patent landscape, comprehensive FTO analysis is essential to identify potential overlaps with existing patents.

  • Opposition and Litigation Risks:
    The patent’s scope might be susceptible to validity challenges if prior art disclosures or similar compounds exist.


Regulatory and Commercial Implications

Patent's Role in Commercial Strategy
Protection conferred by SMT201400138 is critical for securing exclusive market rights, enabling recoupment of R&D investments and attracting licensing deals.

Patent Life and Extension Opportunities
Given the typical 20-year patent term from filing, patent maintenance in multiple jurisdictions ensures market exclusivity during the drug’s life cycle.


Conclusion

Patent SMT201400138 represents a targeted effort by San Marino to secure innovation rights over a pharmaceutical compound or formulation. Its scope, defined by a combination of broad and specific claims, is strategically crafted to withstand challenges and secure market exclusivity. The broader patent landscape indicates a highly competitive environment, emphasizing the importance of precise claim drafting and thorough landscape analysis.


Key Takeaways

  • Scope is likely centered on a novel chemical entity or formulation with potential therapeutic application.
  • Claims probably combine broad compound or method claims with narrower dependent claims for specific embodiments.
  • Patent landscape analysis reveals active competition involving similar compounds, synthetic methods, and formulations.
  • Strategic patent positioning is vital to defend against prior art challenges and maximize market rights.
  • Global patent protection, including in key markets, is essential for commercial success.

FAQs

1. How does patent SMT201400138 compare to other drug patents in terms of breadth?
While specific claim language is needed for detailed comparison, most pharmaceutical patents balance broad protective claims with narrower embodiments to avoid prior art invalidation.

2. What is the typical lifespan of this patent, and when might it expire?
Assuming a filing date around 2014, the patent would generally expire around 2034, subject to maintenance fees and regional adjustments.

3. Can other companies develop similar drugs without infringing this patent?
Infringement depends on the scope of claims. Developing chemical analogs outside the claimed structures or different therapeutic methods may avoid infringement.

4. How does patent landscape analysis aid in drug development?
It identifies existing protections and gaps, guiding innovation strategies and minimizing infringement risks.

5. What should stakeholders do to ensure robust patent protection?
They should conduct thorough prior art searches, draft claims to cover multiple embodiments, and seek international patent protection strategically.


References

  1. Patent SMT201400138 documentation (as available publicly in San Marino IP records)
  2. WIPO PATENTSCOPE, related patent filings and family data
  3. European Patent Office (EPO) Patent Landscape Reports
  4. USPTO Patent Classification and Search Tools
  5. Relevant journal articles on pharmaceutical patent strategies

Note: Exact claims text and filing details are required for definitive analysis. This report is a generalized, informed overview assuming standard practices in pharmaceutical patent drafting and landscape considerations.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.